company background image
524572 logo

Pharmaids Pharmaceuticals BSE:524572 Stock Report

Last Price

₹81.65

Market Cap

₹2.9b

7D

6.1%

1Y

13.9%

Updated

11 Jan, 2025

Data

Company Financials

Pharmaids Pharmaceuticals Limited

BSE:524572 Stock Report

Market Cap: ₹2.9b

524572 Stock Overview

Provides specialty chemicals, skin care and hospital care products, and generics in India. More details

524572 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Pharmaids Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Pharmaids Pharmaceuticals
Historical stock prices
Current Share Price₹81.65
52 Week High₹87.46
52 Week Low₹31.90
Beta0.47
1 Month Change39.55%
3 Month Change104.28%
1 Year Change13.89%
3 Year Change378.89%
5 Year Changen/a
Change since IPO2,168.06%

Recent News & Updates

Recent updates

Shareholder Returns

524572IN PharmaceuticalsIN Market
7D6.1%-4.0%-4.5%
1Y13.9%29.0%11.1%

Return vs Industry: 524572 underperformed the Indian Pharmaceuticals industry which returned 29% over the past year.

Return vs Market: 524572 exceeded the Indian Market which returned 11.1% over the past year.

Price Volatility

Is 524572's price volatile compared to industry and market?
524572 volatility
524572 Average Weekly Movement12.0%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524572's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 524572's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
198925Prasad S.www.pharmaids.com

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides specialty chemicals, skin care and hospital care products, and generics in India. The company offers specialty chemicals, including retinol, DL alpha tocopherol, D pantothenate, cyanocobalamin, pyridoxine Hcl, thiamine, nicotinic acid, water sol. vitamin E, coenzyme Q10, and D-biotin; and skin care products, such as best care hands, hands sanitizers, moisturizing creams, skinsure plus, skinsure ultra, alcohol gels, and barrier creams.

Pharmaids Pharmaceuticals Limited Fundamentals Summary

How do Pharmaids Pharmaceuticals's earnings and revenue compare to its market cap?
524572 fundamental statistics
Market cap₹2.88b
Earnings (TTM)-₹110.68m
Revenue (TTM)₹250.82m

11.5x

P/S Ratio

-26.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524572 income statement (TTM)
Revenue₹250.82m
Cost of Revenue₹195.38m
Gross Profit₹55.44m
Other Expenses₹166.12m
Earnings-₹110.68m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.14
Gross Margin22.11%
Net Profit Margin-44.13%
Debt/Equity Ratio16.0%

How did 524572 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 19:55
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmaids Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution